Table 3.
Regression analysis of the variables used to predict the presence of ADRs.
| Variables | β | SE(β) | p * | OR | 95% CI for OR | Risk Score |
|---|---|---|---|---|---|---|
| Endocrine system drugs | 2.443 | 0.522 | <0.001 | 11.508 | 4.134–32.039 | 2 points |
| Cardiovascular system drugs | 2.702 | 0.501 | <0.001 | 14.902 | 5.583–39.774 | 3 points |
| Diseases of the circulatory system | 1.354 | 0.596 | 0.023 | 3.872 | 1.203–12.460 | 1 point |
| Nervous system drugs | 1.026 | 0.394 | 0.009 | 2.790 | 1.288–6.042 | 1 point |
| Parenteral nutrition treatment | 1.344 | 0.402 | 0.001 | 3.835 | 1.745–8.431 | 1 point |
* p < 0.05 was considered statistically significant. OR: Odds ratio, CI: Confidence interval.